BioHealth News Archive
Emergent BioSolutions to acquire PaxVax and two travel vaccines in $270M deal | Fierce Pharma
After getting smallpox vaccine ACAM2000 from Sanofi and an anthrax treatment called raxibacumab from GlaxoSmithKline, Emergent BioSolutions is buying again, this time an entire…
Read More
Don’t get distracted over ARPA-H fight; let’s win the bigger prize | Maryland Daily Record
Congress has approved a new agency — the Advanced Research Projects Agency for Health (ARPA-H) — that will ‘supercharge’ breakthrough medical research and provide…
Read More
Eyeing $1B in annual sales, Emergent BioSolutions to buy Narcan maker Adapt for $735M | Fierce Pharma
Emergent BioSolutions is mobilizing its M&A war chest again. Hard on the heels of its $270 million deal for vaccine expert PaxVax, the frequent…
Read More
8 new high priority funding opportunities
We just released 8 new high priority funding opportunities where your company can make a difference in meeting the needs of cancer patients… Please…
Read More
Maryland’s RoosterBio and Seattle’s AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
SEATTLE, Aug. 16, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today a strategic partnership with RoosterBio…
Read MoreD.C. Area Life Sciences Market Down to 1.4% Vacancy – Commercial Observer
The Washington, D.C./Baltimore region continued to see a tightening in its life sciences real estate market. In particular, the region saw a decrease in…
Read More
Bio Tax Credit | Maryland Department of Commerce
The fiscal year 2022 program is now closed. The fiscal year 2023 program will begin accepting applications as follows: Commerce will begin accepting Form…
Read More
Novavax Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and Older
Aug 15, 2022 If authorized, Novavax' vaccine would be the first protein-based COVID-19 booster for adults If authorized, the Novavax COVID-19 Vaccine, Adjuvanted could…
Read More
Technical.ly: 2 new medtech startups will spin out of Johns Hopkins research fund grants
Two new medical startups, focusing on addressing vision loss and catheter-associated urinary tract infections (UTIs), are on the horizon thanks to the $200,000 in…
Read More
Chancellor’s Message: VISION 2030 — From Excellence to Preeminence
VISION 2030: From Excellence to Preeminence This summer, the University System of Maryland unveiled a new 10-year strategic plan—Vision 2030: From Excellence to Preeminence.…
Read More
Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases
WALTHAM, Mass. and DUBLIN, Aug. 15, 2022 /PRNewswire/ -- Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Horizon…
Read More
World’s fastest airliner ‘Overture’ to usher in era of supersonic travel
The world hasn’t seen commercial supersonic travel in nearly 20 years since the Concorde was retired in 2003, but all that is about to…
Read MoreAlexandria Real Estate Equities and the Transformation of Life Science Real Estate | Nareit
A quarter century after it began life as a garage start-up, Alexandria Real Estate Equities, Inc.’s (NYSE: ARE) decision to focus on the niche…
Read More
NSF Awards $10M To UMBC To Expand Successful Initiative Developing Underrepresented Postdocs In STEM – UMBC: University Of Maryland, Baltimore County
UMBC will expand its work boosting diversity in academia from Maryland to the national level through a new NSF INCLUDES Alliance: Re-Imagining STEM Equity…
Read More
Ellume welcomes Congressman David Trone, Senator Ben Cardin, Senator Chris Van Hollen and National Institute of Standards and Technology (NIST) Manufacturing Extension Partnership Director Laurie Locascio
It was a pleasure to welcome Congressman David Trone, Senator Ben Cardin, Senator Chris Van Hollen and National Institute of Standards and Technology (NIST)…
Read More